What is the efficacy of Cerena Transcranial Magnetic Stimulator (Cerena TMS) for the treatment of migraine headache?

Updated: Oct 01, 2021
  • Author: Jasvinder Chawla, MD, MBA; Chief Editor: Helmi L Lutsep, MD  more...
  • Print

In December 2013, the FDA approved the Cerena Transcranial Magnetic Stimulator (Cerena TMS), the first device to relieve pain caused by migraine headache with aura for use in patients aged 18 years and older. Users hold the device with both hands to the back of the head and press a button to release a pulse of magnetic energy that stimulates the occipital cortex. The recommended daily usage of the device is not to exceed one treatment in 24 hours. [84, 85]

Approval for the Cerena TMS was based on a randomized study of 201 patients with moderate to strong migraine headaches, in which 39% of the patients using the device were pain-free 2 hours following its use, relative to 22% of control patients (therapeutic gain: 17%). [86, 87] At 24 hours, nearly 34% of patients treated with the device were pain-free, compared with 10% of the control group.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!